Antimicrobial resistance currently accounts for approximately 700,000 deaths globally each year, yet projections reveal a catastrophic trajectory if investment gaps persist. Without adequate funding and coordinated action, annual AMR-related deaths could surge to 10 million by 2050, creating a public health crisis exceeding current infectious disease mortality rates.
These alarming projections underscore the economic imperative for immediate investment. The potential economic impact of uncontrolled AMR could reach 100 trillion dollars by 2050, far exceeding the cost of preventive action today. The World Organisation for Animal Health emphasizes that current funding levels are insufficient to implement the surveillance systems, diagnostic capacity, and antimicrobial stewardship programmes necessary to reverse this trajectory across human, animal, and environmental health domains.
Read the full article on GMJ Newsroom.
Was this article helpful?
